Breakthrough pancreatic cancer treatment could double survival time

Chronological Source Flow
Back

AI Fusion Summary

A new drug, daraxonrasib, could double survival time for advanced pancreatic cancer patients, according to a study presented at ASCO and published in NEJM. Researchers also explore its effectiveness in lung, ovarian, and colorectal cancers.
Community Comments
Loading updates...
0